Want to join the conversation?
In 4Q16, $AZO's GM was 52.8% of sales, up 30BP. The improvement in GM was attributable to lower acquisition costs partially offset by higher supply chain costs associated with the current year initiatives. EBIT was $703MM, up 5.1% over 4Q15. EBIT margin was 20.7%. Debt outstanding at 4Q16-end was $4.9Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?